Summary
Updated Aug 30, 2026
Christopher M. Starr is Director of Monopar Therapeutics (MNPR). 1 SEC Form 4 filing on record, dated 14 July 2025. Most recent open-market trade: sold $672K of MNPR on 14 July 2025. Lifetime open-market sales: $672K.
Recent Transactions
2Every recent SEC Form 4 transaction Christopher M. Starr has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher M. Starr files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Tactic Pharma LLC - $35.00M of MNPR open-market activity in the last 12 months
- Kim R. Tsuchimoto - $911K of MNPR open-market activity in the last 12 months
- Raymond Anderson - $703K of MNPR open-market activity in the last 12 months
- Patrice Rioux - $111 of MNPR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher M. Starr?
Christopher M. Starr is a corporate insider, tracked as Director of Monopar Therapeutics (MNPR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Christopher M. Starr last file a Form 4?
The only primary Form 4 on record is dated 14 July 2025.
Has Christopher M. Starr been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($672K) across all tracked filings.
Where can I see all of Christopher M. Starr's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Christopher M. Starr and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
